Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis

Abstract

The purpose of this study was to assess adherence to vascular protection drugs in diabetic patients using a cohort of diabetic patients aged ≥30 years, covered by the public drug insurance in the province of Quebec, excluding gestational diabetes and patients who were hopitalized or died during the 1-year follow-up. Drug adherence was measured using the medication possession ratio. Multivariate analyses, including logit and multinomial logit were used. Of the 170,381 diabetics (mean age: 62 ± 14 years), 18% and 32% were regular users of ASA and ACEIs/ARBs, respectively. Regular use increased with age (p<0.0001) and comorbidities (p<0.0001). Rural inhabitants were more likely to use ACEIs/ARBs (OR: 1.29; 95% CI: 1.26—1.32) and to be regular users (OR: 1.36; 95% CI: 1.32—1.39). Similar results were found for ASA. In conclusion, despite the high cardiovascular risks associated with diabetes, less than one-third of diabetic adults took vascular-protection drugs regularly. This important issue needs proper attention.

Keywords

adherence diabetes medical record medication use vascular protection

References

Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the prevention and Management of Diabetes in Canada . Can J Diabetes 2003; 27(Suppl 2):S37-S42, S58-S65.

Meltzer S. , Leiter L. , Daneman D. , Gerstein H C. , Lau D. , Ludwig S. , Yale JF , Zinman B. , Lillie D. , Steering and Expert Committees. 1998 clinical practice guidelines for the management of diabetes in Canada. Can Med J 1998; 159(8 Suppl):S1-S29.

Clinical Practice Guidelines Expert Committee , Fichett D. , Kraw M. Vascular Protection in people with diabetes . Can J Diabetes 2008; 32(Suppl 1):S102- S106.

Vanasse A. , Courteau J. , Niyonsenga T. Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients’ survival when delivered as usual care. BMC Cardiovasc Disord 2006; 6: 21.

DiMatteo MR Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004 ; 42: 200-209.

Cooke CE , Fatodu H. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. J Manag Care Pharm 2006; 12: 649-655.

Sikka R. , Xia F. , Aubert RE Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11: 449-457.

Klarin I. , Fastbom J. , Wimo A. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Saf 2003; 12: 669-678.

Palin JA , Zumbo BD Measurement of health care utilization in Canada: Agreement between surveys and administrative records. Catalogue no. 11-522-XIE, XIE, 2003.

10.

Statistics Canada http://www.statcan.ca/english/research/92F0138MIE/2008002/discussion-en.htm (accessed 1 September 2008)

11.

Loslier J. , Vanasse A. , Niyonsenga T. , Courteau J. , Orzanco G. , Hemiari A. Myocardial infarction in Quebec rural and urban populations between 1995 and 1997. Can J Rural Med 2007; 12: 95-102.

12.

Sirois C. , Poirier P. , Moisan J. , Grégoire JP

The benefit of aspirin therapy in type 2 diabetes: what is the evidence?

Int J Cardiol 2008; 129: 172-179.